BELSOMRA- suvorexant tablet, film coated
Merck Sharp & Dohme LLC
----------
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: 2/2023 |
MEDICATION GUIDE BELSOMRA® (bell-SOM-rah) suvorexant Tablets C-IV |
|
What is the most important information I should know about BELSOMRA? BELSOMRA may cause serious side effects including:
See "What are the possible side effects of BELSOMRA?" for more information about side effects. |
|
What is BELSOMRA?
BELSOMRA is a federally controlled substance (C-IV) because it can be abused or cause dependence. Keep BELSOMRA in a safe place to prevent misuse and abuse. Selling or giving away BELSOMRA may harm others and is against the law. Tell your doctor if you have ever abused or have been dependent on alcohol, prescription medicines or street drugs. |
|
Who should not take BELSOMRA? | |
Do not take BELSOMRA if you fall asleep often at unexpected times (narcolepsy). | |
What should I tell my doctor before taking BELSOMRA? | |
Before taking BELSOMRA, tell your doctor about all of your medical conditions, including if you:
|
|
Tell your doctor about all the medicines you take, including prescription or over-the-counter medicines, vitamins, or herbal supplements. Medicines can interact with each other, sometimes causing serious side effects. Do not take BELSOMRA with other medicines that can make you sleepy unless your doctor tells you to. | |
Know the medicines you take. Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine. | |
How should I take BELSOMRA?
|
|
What should I avoid while taking BELSOMRA?
|
|
What are the possible side effects of BELSOMRA? See "What is the most important information I should know about BELSOMRA?" BELSOMRA may cause serious side effects including: |
|
|
|
The most common side effects of BELSOMRA include drowsiness the next day after you take BELSOMRA. The following additional side effects have been reported with BELSOMRA: abnormal dreams. |
|
These are not all the possible side effects of BELSOMRA. For more information, ask your doctor or pharmacist. |
|
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | |
How should I store BELSOMRA?
|
|
General information about the safe and effective use of BELSOMRA. | |
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use BELSOMRA for a condition for which it was not prescribed. Do not give BELSOMRA to other people, even if they have the same symptoms that you have. It may harm them. | |
This Medication Guide summarizes the most important information about BELSOMRA. You can ask your pharmacist or doctor for information about BELSOMRA that is written for health professionals. | |
For more information, go to www.BELSOMRA.com or call 1-800-622-4477. | |
What are the ingredients in BELSOMRA? | |
Active ingredient: Suvorexant | |
Inactive ingredients: Croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and polyvinylpyrrolidone/vinyl acetate copolymer (copovidone). The film coating contains: hypromellose, lactose monohydrate, titanium dioxide, and triacetin. The film coating for the 5 mg tablets also contains iron oxide black and iron oxide yellow, and the film coating for the 10 mg tablets also contains FD&C Blue #1/Brilliant Blue FCF Aluminum Lake and iron oxide yellow. | |
Distributed by: Merck Sharp & Dohme LLC Rahway, NJ 07065, USA |
|
For patent information: www.msd.com/research/patent | |
Copyright © 2014-2023 Merck & Co., Inc., Rahway, NJ, USA, and its affiliates.
All rights reserved. |
|
usmg-mk4305-t-2302r006 |